Garry Nicholson

Mr. Garry A. Nicholson is an Independent Director at TScan Therapeutics, Inc., a Chairman at Abdera Therapeutics, Inc. and an Independent Director at Avenzo Therapeutics, Inc. /New/.
He is on the Board of Directors at TScan Therapeutics, Inc., Avenzo Therapeutics, Inc. and Avenzo Therapeutics, Inc. /New/.
Mr. Nicholson was previously employed as a Chairman by Day One Biopharmaceuticals, Inc., an Independent Director by NextCure, Inc., an Independent Director by Turning Point Therapeutics, Inc., an Independent Director by Personal Genome Diagnostics, Inc., a Chairman by G1 Therapeutics, Inc., an Independent Director by Five Prime Therapeutics, Inc., a President, Chief Executive Officer & Director by XTuit Pharmaceuticals, Inc., and a President-Pfizer Oncology by Pfizer Inc. He also served on the board at Tmunity Therapeutics, Inc., SQZ Biotechnologies Co., Tesaro, Inc. and The Pfizer Foundation, Inc. He received his undergraduate degree from The University of North Carolina at Chapel Hill and an MBA from the University of South Carolina.